Trupti D. Vardam

1.3k citations
10 papers · 546 indexed · h-index 8
Topics
Immunotherapy and Immune Responses (4 papers)CAR-T cell therapy research (3 papers)Immune Response and Inflammation (2 papers)
Partner nations
United StatesGermany

In The Last Decade

Trupti D. Vardam

10 papers receiving 536 citations

Peers

Trupti D. Vardam
Comparison fields: 5 of 77
  • Oncology 213
  • Molecular Biology 187
  • Immunology 176
  • Biomedical Engineering 124
  • Surgery 83
Replace Louise Tatton with:
Louise Tatton United Kingdom
Liam M. Casey United States
Sara Bolis Switzerland
Adel Ersek United Kingdom
Dagmar Pfeiffer Austria
Spencer K. Sullivan United States
Zhiyuan Zheng China
Yingjie Nie China
Trupti D. Vardam relative to Louise Tatton United Kingdom Louise Tatton's profile →
Citations per field
00.5×3.7×
Louise Tatton · 1×
Citations per year

Countries citing papers authored by Trupti D. Vardam

Since Specialization
Citations

This map shows the geographic impact of Trupti D. Vardam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trupti D. Vardam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trupti D. Vardam more than expected).

Fields of papers citing papers by Trupti D. Vardam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trupti D. Vardam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trupti D. Vardam. The network helps show where Trupti D. Vardam may publish in the future.

Co-authorship network of co-authors of Trupti D. Vardam

This figure shows the co-authorship network connecting the top 25 collaborators of Trupti D. Vardam. A scholar is included among the top collaborators of Trupti D. Vardam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trupti D. Vardam. Trupti D. Vardam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 22
2 49
3 7
4 14
5 57
6 1
7 121
8 201
9 17
10 57

About Trupti D. Vardam

Trupti D. Vardam is a scholar working on Immunology, Genetics and Oncology, having authored 10 papers that have together received 546 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (176 citations), Oncology (213 citations) and Genetics (59 citations). Trupti D. Vardam has collaborated with scholars based in United States and Germany. Frequent co-authors include Sharon S. Evans, Michelle M. Appenheimer, Heinz Baumann, Lei Zhou, Jason B. Muhitch, Rakesh K. Jain, Daniel T. Fisher, Sandra O. Gollnick, Dan G. Duda and Joseph J. Skitzki. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026